The Annexin V–FITC/PI assay revealed that when the HCC cells were treated with a combination of 125I and LBP, cellular apoptosis was significantly higher than that observed when the cells were treated with 125I or LBP alone (Fig. 1c). The gene discussed is ANXA5; the disease is hepatocellular carcinoma.